K2 Principal Fund’s Arena Pharmaceuticals Inc ARNA Stock Holding History

K2 Principal Fund’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,400	Closed	-$502K	–	463
2021 Q4	$502K	Buy	+5,400	New	+$356K	0.03%	219

K2 Principal Fund's ARNA Position: Q1 2022 in Review

K2 Principal Fund sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,400 shares — an estimated $502K sold.

K2 Principal Fund first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $502K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

K2 Principal Fund reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
K2 Principal Fund sold 5,400 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $502K.
K2 Principal Fund first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
K2 Principal Fund's Arena Pharmaceuticals Inc position peaked at $502K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on K2 Principal Fund's 13F filing for Q1 2022, filed 16 May 2022.